Effect of anticholinergic burden on the development of dementia in older adults with subjective cognitive decline

Mehmet Ilkin NaharciGulhane Medical Faculty, Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Kecioren, TurkeyCorrespondence[email protected]

Umit CintosunGulhane Training and Research Hospital, Geriatrics Clinic, Kecioren, Turkey

Ahmet OzturkGulhane Training and Research Hospital, Geriatrics Clinic, Kecioren, Turkey

Hasan OztinGulhane Medical Faculty, Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Kecioren, Turkey

Turker TurkerGulhane Medical Faculty, Department of Public Health, University of Health Sciences, Kecioren, Ankara, Turkey

Ergun BozogluGulhane Medical Faculty, Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Kecioren, Turkey

Huseyin DorukGulhane Medical Faculty, Department of Internal Medicine, Division of Geriatrics, University of Health Sciences, Kecioren, Turkey

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Henry Ukachukwu Michael, Okechukwu Enechukwu, Marie-Josée Brouillette, Robyn Tamblyn, Lesley K. Fellows & Nancy E. Mayo. (2023) The Prognostic Utility of Anticholinergic Burden Scales: An Integrative Review and Gap Analysis. Drugs & Aging.
Crossref

Martin Taylor-Rowan, Olga Kraia, Christina Kolliopoulou, Anna H Noel-Storr, Ahmed A. Alharthi, Amanda J Cross, Carrie Stewart, Phyo K Myint, Jenny McCleery & Terry J Quinn. (2022) Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. Cochrane Database of Systematic Reviews 2022:8.
Crossref

Lamya Al Shuhaimi, Martin Henman, Philip McCallion, Mary McCarron & Maire O'Dwyer. (2022) The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review. HRB Open Research 5, pages 63.
Crossref

Martin Taylor-Rowan, Sophie Edwards, Anna H Noel-Storr, Jenny McCleery, Phyo K Myint, Roy Soiza, Carrie Stewart, Yoon Kong Loke & Terry J Quinn. (2021) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews 2021:5.
Crossref

Angela Lisibach, Valérie Benelli, Marco Giacomo Ceppi, Karin Waldner-Knogler, Chantal Csajka & Monika Lutters. (2020) Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. European Journal of Clinical Pharmacology 77:2, pages 147-162.
Crossref

Ashley Kable, Anne Fullerton, Samantha Fraser, Kerrin Palazzi, Carolyn Hullick, Christopher Oldmeadow, Dimity Pond, Andrew Searles, Kim Edmunds & John Attia. (2019) Comparison of Potentially Inappropriate Medications for People with Dementia at Admission and Discharge during An Unplanned Admission to Hospital: Results from the SMS Dementia Study. Healthcare 7:1, pages 8.
Crossref

Effect of anticholinergic burden on the development of dementia in older adults with subjective cognitive decline

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effect of anticholinergic burden on the development of dementia in older adults with subjective cognitive decline

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date